Literature DB >> 18973603

Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression.

Joyce Colussi-Mas1, Susan Schenk.   

Abstract

The behavioral profile in response to (+/-)-3,4-methylenedioxymethamphetamine (MDMA) is characterized by acute hyperlocomotion that is primarily restricted to the periphery of the open field, whereas behavioral sensitization to MDMA reflects a selective increase in activity in the central zone, suggesting that acute effects and sensitization might rely on neuroadaptations in different systems. This study was thus undertaken to determine whether specific changes in neuronal activation could be correlated with either the acute or sensitized behavioral responses to MDMA. Animals received five daily intraperitoneal (i.p.) injections of saline or MDMA (10 mg/kg). Two days later, animals that received saline were injected with saline or MDMA (5 or 10 mg/kg, i.p.). Animals pretreated with MDMA were injected with saline or MDMA (5 mg/kg, i.p.). Locomotor activity was measured in an open field, and neuronal activation was examined by immunodetection of Fos. Acute MDMA exposure produced a dose-dependent increase in locomotion in the peripheral zone of the open field that was related to an increase in Fos expression in the ventromedial shell of the nucleus accumbens, ventral pallidum, several hypothalamic nuclei and rhomboid thalamic nucleus. Following repeated, intermittent exposure to MDMA, drug-produced hyperactivity became sensitized but, unlike the effect of increasing dose, the increased response was due to increased activity and time spent in the central zone. Furthermore, the sensitized behavioral response was related to changes in Fos expression in the lateral shell of the nucleus accumbens, central nucleus of the amygdala and anteromedial part of the lateral habenula. This study identifies neural substrates that might specifically underlie the sensitized response to MDMA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973603     DOI: 10.1111/j.1460-9568.2008.06467.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms.

Authors:  Ross van de Wetering; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2017-02-10       Impact factor: 4.530

2.  Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.

Authors:  Petra S van Nieuwenhuijzen; Leonora E Long; Glenn E Hunt; Jonathon C Arnold; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2010-08-21       Impact factor: 4.530

3.  MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.

Authors:  Ronald M Salomon; John Karageorgiou; Mary S Dietrich; Jessica Y McLellan; Evonne J Charboneau; Jennifer U Blackford; Ronald L Cowan
Journal:  Drug Alcohol Depend       Date:  2011-07-31       Impact factor: 4.492

4.  Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions.

Authors:  Daniel L Albaugh; Jennifer A Rinker; Michael H Baumann; Jacquelyn R Sink; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2011-03-05       Impact factor: 4.530

5.  A genetic reduction in the serotonin transporter differentially influences MDMA and heroin induced behaviours.

Authors:  Bridget W Brox; Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2018-03-21       Impact factor: 4.530

6.  A sensitizing D-amphetamine dose regimen induces long-lasting spinophilin and VGLUT1 protein upregulation in the rat diencephalon.

Authors:  Steven R Boikess; Steven J O'Dell; John F Marshall
Journal:  Neurosci Lett       Date:  2009-11-20       Impact factor: 3.046

Review 7.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

8.  Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.

Authors:  Maria Elena Reveron; Esther Y Maier; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2009-11-03       Impact factor: 3.332

9.  Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists.

Authors:  Sarah Bradbury; David Gittings; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2012-05-05       Impact factor: 4.530

10.  Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats.

Authors:  Katharine A Brennan; Fraser Putt; Penelope Truman
Journal:  Psychopharmacology (Berl)       Date:  2013-03-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.